Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Other financing activities (2018 - 2024)

BioCorRx's Other financing activities history spans 6 years, with the latest figure at $2584.0 for Q1 2024.

  • For Q1 2024, Other financing activities fell 91.07% year-over-year to $2584.0; the TTM value through Dec 2024 reached $2584.0, changed N/A, while the annual FY2024 figure was $2584.0, N/A changed from the prior year.
  • Other financing activities for Q1 2024 was $2584.0 at BioCorRx, up from -$28949.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $28949.0 in Q1 2023 and bottomed at -$28949.0 in Q2 2023.
  • The 3-year median for Other financing activities is -$4750.0 (2022), against an average of -$4483.2.
  • The largest YoY upside for Other financing activities was 91.07% in 2024 against a maximum downside of 91.07% in 2024.
  • A 3-year view of Other financing activities shows it stood at -$4750.0 in 2022, then crashed by 509.45% to -$28949.0 in 2023, then surged by 108.93% to $2584.0 in 2024.
  • Per Business Quant, the three most recent readings for BICX's Other financing activities are $2584.0 (Q1 2024), -$28949.0 (Q2 2023), and $28949.0 (Q1 2023).